The estimated Net Worth of Frederic Vanderhaegen is at least $15.7 Миллион dollars as of 25 August 2023. Mr. Vanderhaegen owns over 25,000 units of Avantor stock worth over $4,325,379 and over the last 5 years he sold AVTR stock worth over $8,308,234. In addition, he makes $3,096,540 as Executive Vice President - Americas and Europe at Avantor.
Sign up
Mr. Vanderhaegen AVTR stock SEC Form 4 insiders trading
Frederic has made over 5 trades of the Avantor stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 25,000 units of AVTR stock worth $536,750 on 25 August 2023.
The largest trade he's ever made was selling 140,804 units of Avantor stock on 11 November 2021 worth over $5,395,609. On average, Frederic trades about 11,518 units every 43 days since 2020. As of 25 August 2023 he still owns at least 160,735 units of Avantor stock.
You can see the complete history of Mr. Vanderhaegen stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Frederic Vanderhaegen biography
Frederic Vanderhaegen serves as Executive Vice President - Americas and Europe of the Company. Frederic Vanderhaegen is our Executive Vice President, Europe, a position he has held since October 2018. Mr. Vanderhaegen joined us from Ortho Clinical Diagnostics, an in vitro diagnostics company, where he served as Vice President and General Manager, EMEA from June 2015 to October 2018. Prior to Ortho Clinical Diagnostics, Mr. Vanderhaegen acted as Vice President of Sales at Beckman Coulter, a company that develops, manufactures and markets diagnostic systems for complex biomedical testing, from October 2012 to June 2015.
What is the salary of Frederic Vanderhaegen?
As the Executive Vice President - Americas and Europe of Avantor, the total compensation of Frederic Vanderhaegen at Avantor is $3,096,540. There are 5 executives at Avantor getting paid more, with Michael Stubblefield having the highest compensation of $16,995,300.
How old is Frederic Vanderhaegen?
Frederic Vanderhaegen is 52, he's been the Executive Vice President - Americas and Europe of Avantor since 2020. There are 20 older and 10 younger executives at Avantor. The oldest executive at Avantor Inc. is Rajiv Gupta, 74, who is the Chairman of the Board.
What's Frederic Vanderhaegen's mailing address?
Frederic's mailing address filed with the SEC is RADNOR CORPORATE CENTER, BUILDING ONE,, SUITE 200, 100 MATSONFORD ROAD, RADNOR, PA, 19087.
Insiders trading at Avantor
Over the last 5 years, insiders at Avantor have traded over $3,149,576,044 worth of Avantor stock and bought 27,800 units worth $584,024 . The most active insiders traders include Mountain Investments Iii, L..., Jo Natauri и Sachs & Co. Llc Stone Bridg.... On average, Avantor executives and independent directors trade stock every 21 days with the average trade being worth of $48,107,115. The most recent stock trade was executed by Steven W Eck on 5 September 2024, trading 3,525 units of AVTR stock currently worth $88,337.
What does Avantor do?
based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com
What does Avantor's logo look like?
Complete history of Mr. Vanderhaegen stock trades at Avantor
Avantor executives and stock owners
Avantor executives and other stock owners filed with the SEC include:
-
Michael Stubblefield,
President, Chief Executive Officer, Director -
Thomas Szlosek,
Chief Financial Officer, Executive Vice President -
Michael Stubblefield,
Pres, CEO & Director -
Gerard Brophy,
Executive Vice President - Biopharma Production -
Devashish Ohri,
Executive Vice President - AMEA -
Frederic Vanderhaegen,
Executive Vice President - Americas and Europe -
Thomas A. Szlosek,
Exec. VP & CFO -
Frederic Vanderhaegen,
Exec. VP of Americas & Europe -
Dr. Gerald Brophy Ph.D.,
Exec. VP of Biopharma Production -
Michael Wondrasch,
Exec. VP & Chief Information Officer -
Rajiv Gupta,
Chairman of the Board -
Jonathan Peacock,
Independent Director -
Christi Shaw,
Independent Director -
Rakesh Sachdev,
Independent Director -
Juan Andres,
Independent Director -
Gregory Summe,
Independent Director -
Michael Severino,
Independent Director -
Jo Natauri,
Director -
Andre Moura,
Director -
Matthew Holt,
Director -
Steven Eck,
Senior Vice President, Chief Accounting Officer -
Mark Murray,
Executive Vice President of the Biomaterials and Advanced Technologies Platform -
Sven Henrichwark,
Executive Vice President of APAC -
Tanya Foxe,
Executive Vice President - Global Operations and Supply Chain -
Christophe Couturier,
Executive Vice President - Services, Strategy and Business Transformation -
James Bramwell,
Executive Vice President - Strategic Partners -
Justin Miller,
Executive Vice President, General Counsel, Secretary -
Michael Wondrasch,
Executive Vice President, Chief Information Officer -
Eric McAllister,
Chief Human Resource Officer, Executive Vice President -
Allison K. Hosak,
Sr. VP of Global Communications & Brand -
Justin M. Miller Esq.,
Exec. VP, Gen. Counsel & Sec. -
Tommy J. Thomas CPA,
VP of Investor Relations -
Steven W. Eck,
Sr. VP, Corp. Controller & Chief Accounting Officer -
Sheri Lewis,
Exec. VP, Global Operations & Supply Chain -
Lan Kang,
Director -
John Carethers,
Director -
Sachs & Co. Llc Stone Bridg...,
-
Sachs & Co. Llc Stone Bridg...,
-
Sheri Lewis,
EVP, Global Ops & Supply Chain -
Mountain Investments Iii, L...,
-
Mala Murthy,
Director -
Brittany Hankamer,
EVP, Chief HR Officer -
Randy Lee Stone,
EVP, Laboratory Solutions -
Corey Walker,
President Laboratory Solutions -
Ashish Kulkarni,
See Remarks -
Sachs & Co. Llcgoldman Sach...,
-
Meghan Henson,
EVP, Chief HR Officer -
Thomas Connolly,
Director -
Joseph R Massaro,
Director -
Kitty Sahin,
EVP, Strategy&Corp Development -
Claudius Sokenu,
EVP, Chief Legal & Compliance -
R. Brent Jones,
EVP, Chief Financial Officer -
Benoit Gourdier,
EVP, Biopharma Production